Zometa Lawsuit Results In $13M Verdict Against Novartis
UPDATED: June 19, 2018
It’s all about you. We want to help you make the right legal decisions.
We strive to help you make confident law decisions. Finding trusted and reliable legal advice should be easy. This doesn't influence our content. Our opinions are our own.
Novartis Pharmaceuticals has lost another product liability lawsuit over its bone-strengthening drugs Zometa – this time to the tune of $13 million. It is another in the string of losses for the pharmaceutical giant who juries say not only knew about the risk of osteonecrosis of the jaw (ONJ), but failed to warn consumers about in fear of losing sales.
ONJ Lawsuits Continue
ONJ lawsuits which allege that manufacturers of bone-strengthening drugs containing bisphosphonates put profits over patient safety continue – and more and more juries are finding that drug companies valued their shareholders more than the people they were supposed to help. Many different drug companies have been sued, including:
- Merck & Company over Fosamax
- Novartis Pharmaceuticals over Reclast, Zometa and Areda
- Procter & Gamble Pharmaceuticals and Sanofi Pharmaceuticals over Actonel
- Procter & Gamble Pharmaceuticals over Didronel
- Roche and GlaxoSmithKline over Boniva
- Sanofi Pharmaceuticals over Skelid
The latest lawsuit took place in North Carolina and concerned Novartis Pharmaceutical's Zometa. In that case, Rita Fussman of Chapel Hill was prescribed Zometa to treat cancer that had metastasized to her bones. She began to experience jaw bone death and couldn't wear her dentures because pieces of bone would continually work their way through her gums.
Her mouth eventually caved in, she died of cancer and her family sued Novartis. A North Carolina jury ruled against the manufacturer to the tune of nearly $13 million – $287,000 for compensatory damages and 12.6 million in punitive damages – although the latter was later reduced pursuant to North Carolina law. Other Zometa lawsuits have resulted in multi-million dollar verdicts or settlements as well.
Hiring A Bisphosphonate Injury Attorney
In addition to ONJ injuries, bisphosphonates have been linked to femur fractures, esophageal disorders and bone and pain swelling – the types of injuries that should be prevented by these drugs. If you've been injured, contact a bisphosphonate injury lawyer to discuss your situation – including what drug you were given, how long you took it and how you were injured. After a free and confidential consultation, you'll be able to find out whether you might be entitled to compensation and if filing a lawsuit is in your best interests.